Dupilumab efficacy and safety in patients with moderate-to-severe COPD with type 2 inflammation: pooled analysis of BOREAS and NOTUS

被引：0
|
作者：
Bhatt, Surya [1 ]
Rabe, Klaus F. [2 ,3 ]
Hanania, Nicola [4 ]
Vogelmeier, Claus F. [5 ]
Bafadhel, Mona [6 ]
Christenson, Stephanie [7 ]
Papi, Alberto [8 ]
Singh, Dave [9 ]
Laws, Elizabeth [10 ]
Akinlade, Bolanle [11 ]
Maloney, Jennifer [11 ]
Lu, Xin [10 ]
Bauer, Deborah [10 ]
Bansal, Ashish [11 ]
Abdulai, Raolat M. [12 ]
Robinson, Lacey B. [12 ]
Bhatt, Surya [1 ]
机构：
[1] Univ Alabama Birmingham, Div Pulm Allergy & Crit Care Med, Birmingham, AL USA
[2] LungenClin Grosshansdorf, Grosshansdorf, Germany
[3] Christian Albrechts Univ Kiel, Airway Res Ctr North, German Ctr Lung Res, Grosshansdorf, Germany
[4] Baylor Coll Med, Dept Med, Sect Pulm & Crit Care Med, Houston, TX USA
[5] Univ Marburg, Dept Med Pulm & Crit Care Med, German Ctr Lung Res, Marburg, Germany
[6] Kings Coll London, Fac Life Sci & Med, Kings Ctr Lung Hlth, Sch Immunol & Microbial Sci, London, England
[7] Univ Calif San Francisco, Div Pulm Crit Care Allergy & Sleep Med, San Francisco, CA USA
[8] Univ Ferrara, Ferrara, Italy
[9] Manchester Univ NHS Fdn Trust, Univ Manchester, Manchester, England
[10] Sanofi, Bridgewater, NJ USA
[11] Regeneron Pharmaceut Inc, Tarrytown, NY USA
[12] Sanofi, Cambridge, MA USA
来源：
EUROPEAN RESPIRATORY JOURNAL | 2024年 / 64卷
关键词：
D O I：
10.1183/13993003.congress-2024.PA4787
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Efficacy of dupilumab in patients with uncontrolled, moderate-to-severe asthma with fungal sensitization
    Corren, Jonathan
    Hanania, Nicola A.
    Busse, William W.
    Sher, Lawrence D.
    Altincatal, Arman
    Hardin, Megan
    Mannent, Leda P.
    Amin, Nikhil
    Lederer, David J.
    Soler, Xavier
    Jacob-Nara, Juby A.
    Rowe, Paul J.
    Deniz, Yamo
    CLINICAL AND EXPERIMENTAL ALLERGY, 2023, 53 (10): : 1020 - 1030
  • [32] Efficacy and tolerance of dupilumab in patients with moderate-to-severe atopic dermatitis and obesity
    Dupuis, Josephine
    Tauber, Marie
    Mahe, Emmanuel
    Jachiet, Marie
    Soria, Angele
    Tetart, Florence
    Puzenat, Eve
    Pasteur, Justine
    Raison-Peyron, Nadia
    Giordano-Labadie, Francoise
    Droitcourt, Catherine
    Leleu, Camille
    Nosbaum, Audrey
    Aubert, Helene
    Moigne, Marie L. E.
    Bernier, Claire
    Barbarot, Sebastien
    Ezzedine, Khaled
    Diaz, Emmanuelle
    Hubiche, Thomas
    Faiz, Sarah
    Azib, Selma
    Dezoteux, Frederic
    Chosidow, Olivier
    Staumont-Salle, Delphine
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2025, 39 (02) : e174 - e178
  • [33] Efficacy And Safety Of Indacaterol 75 G Once Daily In Patients With Moderate-To-Severe COPD
    Kerwin, E. M.
    Meli, J.
    Peckitt, C.
    Lassen, C.
    Kramer, B.
    Filcek, S.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2011, 183
  • [34] Dupilumab Efficacy in Patients with Uncontrolled, Moderate-to-Severe Asthma with Elevated Type 2 Biomarkers and Fixed Airflow Obstruction
    Hanania, N. A.
    Castro, M.
    Bateman, E. D.
    Pavord, I. D.
    Papi, A.
    FitzGerald, J. M.
    Maspero, J. F.
    Katelaris, C.
    Singh, D.
    Daizadeh, N.
    Pandit-Abid, N.
    Ortiz, B.
    Laws, E.
    Jacob-Nara, J. A.
    Rowe, P. J.
    Deniz, Y.
    Lederer, D. J.
    Hardin, M.
    Siddiqui, S.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 205
  • [35] Long-term efficacy of dupilumab in patients with moderate-to-severe type 2 inflammation by age of asthma onset: LIBERTY ASTHMA TRAVERSE study
    Busse, William W.
    Kraft, Monica
    Domingo, Christian
    de Mir, Ines
    Maselli, Diego
    Xia, Changming
    Pandit-Abid, Nami
    Soler, Xavier
    Jacob-Nara, Juby A.
    Sacks, Harry
    Rowe, Paul J.
    Deniz, Yamo
    RESPIROLOGY, 2023, 28 : 11 - 12
  • [36] Impact of dupilumab across seasons in patients with type 2, uncontrolled, moderate-to-severe asthma
    Peters, Anju T.
    Sagara, Hironori
    Corren, Jonathan
    Domingo, Christian
    Altincatal, Arman
    Soler, Xavier
    Pandit-Abid, Nami
    Crikelair, Nora
    Rowe, Paul J.
    Jacob-Nara, Juby A.
    Deniz, Yamo
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2024, 132 (04) : 477 - 484.e4
  • [37] Efficacy and Safety of Itepekimab in Patients with Moderate-to-Severe Asthma
    Wechsler, Michael E.
    Ruddy, Marcella K.
    Pavord, Ian D.
    Israel, Elliot
    Rabe, Klaus F.
    Ford, Linda B.
    Maspero, Jorge F.
    Abdulai, Raolat M.
    Hu, Chih-Chi
    Martincova, Renata
    Jessel, Andreas
    Nivens, Michael C.
    Amin, Nikhil
    Weinreich, David M.
    Yancopoulos, George D.
    Goulaouic, Helene
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (18): : 1656 - 1668
  • [38] Safety Profile of Inhaled Glycopyrronium Twice Daily in Patients With Moderate-to-Severe COPD: Pooled Analysis From Four Clinical Trials
    Kerwin, Edward
    Pedinoff, Andrew
    Miller, S. David
    Franke-Bray, Brigitte
    Di Giovanni, Robert
    Henley, Michelle
    D'Andrea, Peter
    CHEST, 2015, 148 (04)
  • [39] Dupilumab reduced impact of severe exacerbations on lung function in patients with moderate-to-severe type 2 asthma
    Papi, Alberto
    Corren, Jonathan
    Castro, Mario
    Domingo, Christian
    Rogers, Linda
    Chapman, Kenneth R.
    Jackson, Daniel J.
    Daizadeh, Nadia
    Pandit-Abid, Nami
    Gall, Rebecca
    Jacob-Nara, Juby A.
    Rowe, Paul J.
    Deniz, Yamo
    Ortiz, Benjamin
    ALLERGY, 2023, 78 (01) : 233 - 243
  • [40] Dupilumab efficacy in VOYAGE pediatric patients with uncontrolled, moderate-to-severe type 2 inflammatory asthma by allergen sensitization status
    Phipatanakul, W.
    Papadopoulos, N. G.
    Hernandez-Trujillo, V.
    Hamelmann, E.
    Zeiger, R. S.
    Ducharme, F. M.
    Jain, N.
    Xia, C.
    Gall, R.
    Pandit-Abid, N.
    Siddiqui, S.
    Jacob-Nara, J. A.
    Rowe, P. J.
    Deniz, Y.
    ALLERGOLOGIE, 2022, 45 (08) : 604 - 604
12345